Risk of Osteonecrosis of the Jaw in Patients Treated with Zoledronic or Alendronic Acid: A Systematic Review

Risk of Osteonecrosis of the Jaw in Patients Treated with Zoledronic or Alendronic Acid: A Systematic Review

<i>Background and Objectives:</i> Bisphosphonates (BP) like zoledronic acid (ZA) and alendronic acid (AA) are used for osteoporosis (OP) or other bone-related conditions as well as to prevent the spread of metastases and in rheumatoid arthritis treatment. However, they have been associat...

Full description

Saved in:

Bibliographic Details
Main Authors:	Aine Jakonyte, Egle Gustainyte, Zygimantas Petronis, Aviad Hafizov, Audra Janovskiene, Dainius Razukevicius
Format:	Article
Language:	English
Published:	MDPI AG 2025-06-01
Series:	Medicina
Subjects:	alendronate bisphosphonate-associated osteonecrosis of the jaw osteoporosis zoledronic acid
Online Access:	https://www.mdpi.com/1648-9144/61/7/1159
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Medication-related osteonecrosis of the jaw after dental clearance: Prevalence in an oncology center
by: Saad Hajeri, BDS, et al.
Published: (2022-09-01)

Bisphosphonate-related osteonecrosis of the jaw: An enigma among medical practitioners
by: Shalini Krishnan, et al.
Published: (2019-01-01)

ONJ (MRONJ) Update 2024: Osteonecrosis of the Jaw Related to Bisphosphonates and Other Drugs—Prevention, Diagnosis, Pharmacovigilance, Treatment—A National Italian Symposium
by: Vittorio Fusco, et al.
Published: (2025-04-01)

Comparison of the Effectiveness of Conservative and Surgical Treatment of Medication-Related Osteonecrosis of the Jaw: a Systematic Review
by: Rial Seluki, et al.
Published: (2023-12-01)

Microscopic Evaluation of the Effect of Oral Microbiota on the Development of Bisphosphonate-Related Osteonecrosis of the Jaws in Rats
by: Felipe M. Silveira, et al.
Published: (2017-01-01)

Incidence of medication-related osteonecrosis of the jaw and associated antiresorptive drugs in adult Finnish population
by: Miika Kujanpää, et al.
Published: (2025-05-01)

Systematic Review on the Incidence of Bisphosphonate Related Osteonecrosis of the Jaw in Children Diagnosed with Osteogenesis Imperfecta
by: Anusha Adeline Hennedige, et al.
Published: (2014-01-01)

EPIDEMIOLOGICAL INVESTIGATION OF THE CLINICAL MANIFESTATION OF BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAWS IN 112 ONCOLOGY PATIENTS
by: Meri Hristamyan, et al.
Published: (2025-02-01)

Endodontic therapy and Medication-related osteonecrosis of the jaw onset: a scoping review and expert opinion-based qualitative meta-synthesis
by: R. Mauceri, et al.
Published: (2025-08-01)

REVIEW OF BASIC CLINICAL TRIALS OF ALENDRONATE
by: E G Zotkin, et al.
Published: (2010-03-01)

Experimental study of the effect of teriparatide on a medication-related rat model of osteonecrosis of the jaw
by: LIAO Chenyu, et al.
Published: (2024-02-01)

Effectiveness of Leukocyte- and Platelet-rich Fibrin in the Management of Medication-related Osteonecrosis of the Jaws – A Systematic Review
by: Rahul Mohandas, et al.
Published: (2024-01-01)

Bisphosphonate-Related Osteonecrosis of the Jaw Bone: Radiological Pattern and the Potential Role of CBCT in Early Diagnosis
by: James Olutayo, et al.
Published: (2010-04-01)

Prevention Of Drug-Induced Osteonecrosis Of The Jaw In Cancer Patients
by: E. M. Spevak, et al.
Published: (2022-07-01)

Quantitative indices for cone-beam CT assessment of Medication-Related Osteonecrosis of the Jaw – a scoping review
by: Ghaidaa Badabaan, et al.
Published: (2023-02-01)

Education and Communication on the Topic of Osteonecrosis of the Jaw When Taking Bone‐Stabilizing Drugs
by: Franz Gustav Saur, et al.
Published: (2024-12-01)

Systemic Ozone Therapy Improves Oral Hard and Soft Tissue Healing in Medication-Related Osteonecrosis of the Jaw (MRONJ): A Study in Senescent Female Rats
by: Leonardo Alan Delanora, et al.
Published: (2025-05-01)

Novel modified quantitative index for cone-beam CT assessment of medication-related osteonecrosis of the jaw - comparative analysis with original index
by: Ghaidaa Badabaan, et al.
Published: (2023-05-01)

Treatment of bisphosphonate induced osteonecrosis of jaw in rats using an angiogenesis factor (A-Heal) and ABMDO (Autologous Bone Marrow Derived Osteoblasts)
by: Mir Sadat-Ali, et al.
Published: (2022-02-01)

Occlusive denture for the management of medication-related osteonecrosis of the jaw with oronasal communication: A case report
by: Arthur Augusto Martins e Silva, et al.
Published: (2025-06-01)

Effects of discontinuing different antiresorptive regimens on medication-related osteonecrosis of the jaw in patients undergoing dental procedures: a systematic review and network meta-analysis
by: Kasidid Ruksakiet, et al.
Published: (2025-05-01)

Zoledronate-induced orbital and ocular inflammation
by: Julia Dyrda, et al.
Published: (2025-03-01)

MicroRNA-21-5p profile in the alveolar bone following tooth extraction in medication-related osteonecrosis of the jaw rat model
by: Manta Morakotsriwan, et al.
Published: (2024-12-01)

The use of bisphosphonates for the treatment and prevention of osteoporosis
by: O. A. Nikitinskaya, et al.
Published: (2022-08-01)

Denosumab Related Osteonecrosis of Jaw: a Case Report
by: Marco Vinícius de Sales Lima, et al.
Published: (2018-12-01)

Is There an Ideal Concentration of Ozonized Oil for the Prevention and Modulation of Zoledronate-Induced Mandibular Osteonecrosis? A Study on Senescent Rats
by: Mirela Caroline Silva, et al.
Published: (2024-11-01)

A case series and review of canine idiopathic osteonecrosis of the jaw
by: Amy Rossi, et al.
Published: (2025-05-01)

Antiresorptive medication-related osteonecrosis of the jaw: Incidence and preventive measures utilization in cancer patients
by: Salman Ali Alabdali, et al.
Published: (2024-12-01)

Comprehensive Approach to the Treatment and Prevention of Bisphosphonate-Induced Osteonecrosis of the Jaw
by: Pilipov, I.A., et al.
Published: (2025-04-01)

Ibrutinib-associated osteonecrosis of the jaw
by: Annu Singh, et al.
Published: (2024-03-01)

Adaptation of mitochondrial bioenergetics to coenzyme Q deficiency in human endothelial cells after chronic exposure to bisphosphonates
by: Adrianna Budzinska, et al.
Published: (2025-05-01)

Use of Platelet-Rich Fibrin for Jaw Osteonecrosis: A Case Report
by: Petya Kanazirska, et al.
Published: (2020-12-01)

Medication-related osteonecrosis of the jaws: a series of 22 cases highlighting their histopathological features
by: Dandara Andrade de SANTANA, et al.
Published: (2025-06-01)

Zoledronic acid in the treatment of osteoporosis: indications for use
by: Nataliya Vladimirovna Toroptsova, et al.
Published: (2011-06-01)

Dental complications and management of patients on bisphosphonate therapy: A review article
by: Sandeep Kalra, et al.
Published: (2013-01-01)

Dental Implant Placement in Patients on Bisphosphonate Therapy: a Systematic Review
by: Rokas Gelazius, et al.
Published: (2018-10-01)

Generic zoledronic acid for osteoporosis: focus on tolerability and safety
by: N. V. Toroptsova, et al.
Published: (2021-10-01)

Supra-Physiological Levels of Magnesium Counteract the Inhibitory Effect of Zoledronate on RANKL-Dependent Osteoclastogenesis
by: Lorenzo Caselli, et al.
Published: (2025-05-01)

Medication related osteonecrosis (MRONJ) in the management of CTIBL in breast and prostate cancer patients. Joint report by SIPMO AND SIOMMMS
by: Francesco Bertoldo, et al.
Published: (2025-02-01)

Medication-Related Osteonecrosis of the Jaw (MRONJ): A Review of Pathophysiology, Risk Factors, Preventive Measures and Treatment Strategies
by: Raed AlRowis, et al.
Published: (2022-03-01)